The END Fund and Merck KGaA, Darmstadt, Germany Bolster Rwanda’s Plan to Eliminate Schistosomiasis by 2024

The END Fund and Merck KGaA, Darmstadt, Germany Bolster Rwanda’s Plan to Eliminate Schistosomiasis by 2024

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email
Share on print
Print

●      Additional 8 million tablets of praziquantel per year for the treatment of adults

●      Donation supports Rwanda’s strategic plan to eliminate schistosomiasis and other Neglected Tropical Diseases (NTDs) by 2024

NAIROBI, Kenya, January 29, 2021,-/African Media Agency (AMA)/- The END Fund, a private philanthropic initiative solely dedicated to ending the five most common neglected tropical diseases (NTDs), today announced their partnership with Merck KGaA, Darmstadt, Germany, a leading science and technology company, to provide Rwanda with 8 million additional tablets of praziquantel per year. The tablets are needed for treating adults endangered by schistosomiasis. The new partnership supports and amplifies commitments made in Rwanda’s NTD Strategic Plan, which aims to eliminate schistosomiasis and other NTDs as a public health problem by 2024.

“The END Fund is thrilled to deepen its long-standing partnership with Merck KGaA, Darmstadt, Germany, with this generous donation. Through the Deworming Innovation Fund, it will allow our partners in Rwanda to reach more underserved communities with NTD treatments. This supports the government of Rwanda’s efforts to end schistosomiasis as a public health problem, which in turn leads to better educational and economic outcomes,” said Ellen Agler, CEO of the END Fund.

The donation represents a significant contribution to the Deworming Innovation Fund, a four-country initiative of the END Fund to progress towards the elimination of schistosomiasis and intestinal worms in Rwanda, Ethiopia, Kenya, and Zimbabwe.

Annually, an estimated 4.3 million people in Rwanda require preventive treatment for schistosomiasis, of whom 1.6 million are school-aged children. The END Fund has been a key partner for the Rwandan national strategic plan for NTDs in the past and continues to do so through its Deworming Innovation Fund.

To move towards the elimination of schistosomiasis, it is necessary to treat the entire population at risk, including children and adults. Through this partnership, treatment for adults will be made available.

The END Fund and Merck KGaA, Darmstadt, Germany announced their partnership on the occasion of the second World NTD Day on January 30, 2021. The World NTD Day is supported by over 230 international partners to raise awareness for neglected tropical diseases (NTDs) and to call for action to put an end to these diseases.

Since 2011, Merck KGaA, Darmstadt, Germany, has donated more than 15.2 million tablets for the treatment of school-aged children to this East African country.

“Back in 2007, more than a decade ago, our company committed to the fight against schistosomiasis. Today we are taking another important step to eliminate this deadly disease in Rwanda together with the END Fund,” said BelĂ©n Garijo, Vice Chair of the Executive Board and Deputy CEO of Merck KGaA, Darmstadt, Germany. “The additional quantities of praziquantel are urgently needed to support the communities at risk and will bring us one step closer to our goal of a schisto free world.”

Schistosomiasis is a chronic condition and one of the most common and most devastating parasitic diseases in tropical countries. It is estimated that more than 240 million people are infected worldwide and that around 200,000 people die from it each year. The disease is transmitted by parasitic flatworms and the infection rate is particularly high among school-aged children.

The END Fund is the only private philanthropic initiative solely dedicated to ending the most common NTDs. Since 2012, the END Fund has raised more than USD 118 million, treated more than 140 million people with 330 million treatments at a value of more than 620 million dollars, trained over 900,000 health workers, and provided more than 10,000 surgeries to people suffering from blinding trachoma and lymphatic filariasis.

Distributed by  African Media Agency (AMA) on behalf of The END Fund.

About schistosomiasis

Schistosomiasis is a chronic condition and one of the most common and most devastating parasitic diseases in tropical countries. It is estimated that more than 240 million people are infected worldwide and that around 200,000 die from it each year. Flatworms transmit the disease. It is widespread in tropical and subtropical regions where large sections of the populations have no access to clean water and sanitary installations. People become infected with the parasite via contact with freshwater, for example while working, swimming, fishing or washing their clothes. The minuscule larvae penetrate human skin, enter the blood vessels and attack internal organs. The infection rate is particularly high among school-aged children. Praziquantel is the only active ingredient with which all forms of schistosomiasis can be treated. WHO has therefore deemed praziquantel, the most cost-efficient solution for the health of patients in need, as the drug of choice.

About the END Fund

The END Fund is the only private philanthropic initiative solely dedicated to ending the five most common neglected tropical diseases (NTDs), which affect more than 1.7 billion people globally. It efficiently puts private capital to work, advocating for NTD programs that are innovative, integrated, and cost-effective. It facilitates strong partnerships with the private sector and has supported national disease control programs in 30 countries. Since its founding in 2012, with its partners, the END Fund has provided over 740 million donated treatments worth over $1 billion, over 12,900 surgeries for people suffering from the effects of the advanced stages of elephantiasis and trachoma, and trained more than 1.4 million people in NTD control and elimination efforts.

About the END Fund’s Deworming Innovation Fund

Slated to run through 2025, the Deworming Innovation Fund accelerates progress towards tackling parasitic worm infections that affect more than 40 million people in Ethiopia, Rwanda, Zimbabwe, and Kenya. The END Fund will leverage drug donations from key pharmaceutical companies, and support and coordinate with governments and partners to create robust delivery systems. Over the next five years, people at risk of intestinal worms and schistosomiasis in these four strategic countries will benefit from increased access to deworming treatment which will improve overall health and wellbeing.

About Merck KGaA, Darmstadt, Germany

Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2019, Merck KGaA, Darmstadt, Germany, generated sales of € 16.2 billion in 66 countries.

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.

Media Contact
Tegan Mosugu
tmosugu@end.org

You might also enjoy

Subscribe To Our Newsletter

Get updates and learn from the best

Conférence de Presse en Ligne


Les frontiĂšres terrestres ne doivent pas constituer des obstacles Ă  la dissĂ©mination de votre message. GrĂące Ă  notre service de confĂ©rence de presse en ligne, nous vous offrons l’opportunitĂ© de vous rapprocher des mĂ©dias africains, chaque fois que vous en aurez besoin.​

Nos services comprennent:​

​

​

Digital Communications


Today, social networks constitute an organization’s first point of contact with a user and a potential customer. At first glance, you need to convince of the relevance and quality of your content to stimulate and motivate the user to go further. We create consistently inspiring online strategy to meet business objectives, engage stakeholders and enhance our client brand’s reputation internally and externally.​

 

Communication​ digitale


Les rĂ©seaux sociaux reprĂ©sentent aujourd’hui le premier point de contact d’une organisation avec un utilisateur et un client potentiel. Au premier coup d’Ɠil, vous devez le convaincre de la pertinence et de la qualitĂ© de votre contenu pour l’inciter Ă  aller plus loin. Nous crĂ©ons pour vous une stratĂ©gie de communication prĂ©cise et adaptĂ©e sur les rĂ©seaux sociaux pour atteindre les objectifs commerciaux, impliquer les parties prenantes et amĂ©liorer la rĂ©putation de votre marque en interne et en externe.​

Promotion​ d’Ă©vĂ©nements


Le succĂšs d’un Ă©vĂ©nement rĂ©side en moitiĂ© dans sa promotion. Peu importe la beautĂ© de l’évĂ©nement, la qualitĂ© des orateurs et de l’ordre du jour, si personne ne rapporte ou ne parle de votre Ă©vĂ©nement, vos efforts seront vains. Nous vous aidons Ă  façonner votre rĂ©cit et Ă  crĂ©er un engouement autour de votre Ă©vĂ©nement. De l’annonce de l’Ă©vĂ©nement Ă  la tenue de celui-ci, nous accompagnons votre effort de planification et le reflĂ©tons sur toutes les plateformes mĂ©diatiques.​

Formation​ MĂ©diatique


Nous fournissons Ă  vos porte-paroles les outils nĂ©cessaires pour prĂ©senter vos principaux messages et rĂ©pondre avec confiance et cohĂ©rence aux questions. Notre formation est organisĂ©e soit Ă  distance ou en prĂ©sentiel, avec des Ă©tudes de cas rĂ©els et des rĂ©pĂ©titions. Nos clients repartent avec le sentiment d’ĂȘtre Ă  l’aise devant les journalistes et d’agir en tant qu’ambassadeurs de la marque.​

Veille​ MĂ©diatique


Nous mesurons votre portĂ©e en relations publiques et rendons compte des informations de votre industrie et des activitĂ©s de vos  concurrents en surveillant la majoritĂ© des canaux de diffusion dans toute l’Afrique. Une veille mĂ©diatique complĂšte et opportune est essentielle pour s’assurer que vous ne manquez aucune rĂ©fĂ©rence Ă  votre marque, que vous ĂȘtes constamment informĂ© de ce qui se passe dans votre industrie et que vous ĂȘtes prĂȘt Ă  saisir les opportunitĂ©s et Ă  rĂ©duire les risques en temps opportun.​

Relations​ MĂ©dia


Peu importe le lieu oĂč ils se trouvent, nous sommes une source d‘informations fiables pour les journalistes qui Ă©crivent sur l’Afrique. Nous nous connaissons mutuellement et ils nous font confiance, car nous leur fournissons un contenu crĂ©dible qui les aide dans leurs tĂąches. Nous nous entretenons quotidiennement avec des journalistes aux quatre coins du continent, ce qui fait de nous l’un des organismes les plus efficaces pour mener des campagnes de relations avec les mĂ©dias.

Stratégie et développement de contenu


Nous crĂ©ons des stratĂ©gies de communication intelligentes, bien documentĂ©es et spĂ©cialisĂ©es destinĂ©es Ă  vous aider Ă  construire un rĂ©cit fort qui engagera votre audience. Nous travaillons en synergie avec vous afin de rĂ©diger des communiquĂ©s de presse et des articles d’opinions qui alimentent le rĂ©cit de votre entreprise. Notre Ă©quipe a une expĂ©rience approfondie dans la crĂ©ation de rĂ©cits et le dĂ©veloppement de contenu multimĂ©dia.

DIFFUSION DE COMMUNIQUES​ DE PRESSE​


C’est le service phare d’AMA. Nous avons mis en place des canaux de diffusion des communiquĂ©s de presse auprĂšs des journalistes des 54 États africains ainsi qu’auprĂšs des journalistes amĂ©ricains et europĂ©ens couvrant les sujets relatifs aux marchĂ©s Ă©mergents.​

​Nos services comprennent:​

​

​

Event Promotion


Half of the success of an event lays in its promotion. Doesn’t matter how beautiful the event is, how wonderful the speakers and the agenda are, if no one reports or talks about your event, your efforts are gone. We help you shape the narrative and create a drumbeat around your event. From the announce all the way to the outcome of the event, we accompany your planning effort and echo it through all media platforms

Media Training


We provide your spokespeople with the tools to present your key messages and answer questions with confidence and coherence. Our training is organised either remotely or face-to- face, with real case studies and rehearsals. Our clients leave feeling comfortable being in front of reporters and acting as brand ambassadors.

Media Monitoring


We measure and report on
your PR reach, industry news, and competitive activity by monitoring most channels in North, West, Central, East and Southern Africa. Comprehensive and timely media monitoring is critical to ensuring that you don’t miss any reporting of your brand,
you’re constantly informed on what’s going on around your business, and you’re ready to capitalise on opportunities and mitigate
risks in a timely fashion..

Media Relations


We have become an authoritative source of news for reporters writing about Africa, wherever they are. We know them, they know us, and they trust us for providing them with timely and accurate content that helps them do their job. We speak to reporters on a daily basis in all corners of the continent and this makes us one of the most effective agencies in running media relations campaigns.

Strategy & Content Development


We create smart and localised communications strategies to help build a strong narrative that will engage your audiences. We partner with you to create press releases and thought leadership pieces that sustain a drumbeat for your company’s narrative. Our team have deep experience in shaping narratives and developing media content.

PRESS RELEASE WIRE DISTRIBUTION

This is AMA’s flagship service. We have set up channels of distribution towards the journalists of the 54 African states, as well as to American journalists and European journalists covering emerging markets issues.
Our service includes:

Editorial advice

Localised editorial piece when needed

Distribution to the major print, broadcast and online publications along with industry-specific publications

Follow-up calls to secure interview request

Guaranteed distribution to Africa.com

Distribution to Bloomberg, LexisNexis and Thomson Reuters

Social Media Reach: Facebook, Twitter, LinkedIn, Instagram

Full online monitoring and print monitoring when available. Includesreadership stats and Advertising Value Equivalent

Translation in French, Arabic and Portuguese available